If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Grant of Options under SAYE Option Scheme and TVR

3 Dec 2018 10:30

RNS Number : 2151J
CVS Group plc
03 December 2018
 

03 December 2018

CVS Group plc

Grant of Options under CVS Group plc SAYE Option Scheme and

Total Voting Rights

CVS Group plc (the "Company") announces that as part of its all employee Save As You Earn share scheme (the "SAYE Scheme"), Richard Fairman, finance director, elected to participate in the SAYE scheme and was granted 737 SAYE Scheme options.

Eligible employees were invited to subscribe for options over ordinary shares of 0.2 pence each ("Ordinary Shares") with an option price of 830 pence per share, representing a 10% discount to the share price which was calculated using the closing share price prior to the 5th November 2018, being the invite date.

Pursuant to this, a total of 425,974 SAYE Scheme options over Ordinary Shares were granted on 29 November 2018, equating to 0.6% of the current issued ordinary share capital.

The attached notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of options granted on 29 May 2018 under the SAYE Scheme.

In conformity with the Disclosure Guidance and Transparency Rule 5.6.1, the Company notifies the market of the following: The Company's total issued share capital is 70,519,031 ordinary shares of 0.2 pence each with one voting right per share. The Company does not hold any ordinary shares in Treasury. This figure of 70,519,031 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Richard Fairman

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Grant of Options under the SAYE.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Option price of 830p

737

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

e)

 

Date of the transaction

 

 

29 November 2018

f)

 

Place of the transaction

 

 

Off market

 

 

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Richard Fairman, Finance Director

 

 

Tel: 01379 644 288

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell, Jen Boorer

Rachel Hayes

Tel: 020 7496 3000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFKNDBKBDDFBK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.